426
Views
32
CrossRef citations to date
0
Altmetric
Special Report

Tumor lysate-loaded biodegradable microparticles as cancer vaccines

, , , , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Nabeel Kajihara, Yoshino Tanaka, Riko Takeuchi, Takuto Kobayashi, Masafumi Tanji, Tsukasa Ataka, Shiho Nakano, Taisho Yamada, Akinori Takaoka, Yoshinori Hasegawa, Ken-Ichiro Seino & Haruka Wada. (2023) Augmented interferon regulatory factor 7 axis in whole tumor cell vaccines prevents tumor recurrence by inducing interferon gamma-secreting B cells. OncoImmunology 12:1.
Read now
Chia Kohnepoushi, Vahid Nejati, Nowruz Delirezh & Pouria Biparva. (2019) Poly Lactic-co-Glycolic Acid Nanoparticles Containing Human Gastric Tumor Lysates as Antigen Delivery Vehicles for Dendritic Cell-Based Antitumor Immunotherapy. Immunological Investigations 48:8, pages 794-808.
Read now
Janos L. Tanyi & Erin George. (2018) Personalized vaccination against ovarian cancer: what are the possibilities?. Expert Review of Vaccines 17:11, pages 955-958.
Read now

Articles from other publishers (29)

Yingying Hou, Min Chen, Yuan Bian, Xi Zheng, Rongsheng Tong & Xun Sun. (2023) Advanced subunit vaccine delivery technologies: From vaccine cascade obstacles to design strategies. Acta Pharmaceutica Sinica B 13:8, pages 3321-3338.
Crossref
Bianca Ferrarini Zanetti, Camila Pontes Ferreira, José Ronnie Carvalho Vasconcelos & Sang Won Han. (2021) Adjuvant properties of IFN-γ and GM-CSF in the scFv6.C4 DNA vaccine against CEA-expressing tumors. Gene Therapy 30:1-2, pages 41-50.
Crossref
Dixita Ishani Viswanath, Hsuan-Chen Liu, Simone Capuani, Robin Shae Vander Pol, Shani Zakiya Saunders, Corrine Ying Xuan Chua & Alessandro Grattoni. (2022) Engineered implantable vaccine platform for continuous antigen-specific immunomodulation. Biomaterials 281, pages 121374.
Crossref
Neha Raina, Ajay Kumar Pal, Radha Rani, Ajay Sharma & Madhu Gupta. 2022. Nanotherapeutics in Cancer Vaccination and Challenges. Nanotherapeutics in Cancer Vaccination and Challenges 241 258 .
Jiae Koh, Sohyun Kim, Sang Nam Lee, Sun-Young Kim, Jung-Eun Kim, Kyoung Young Lee, Mi Soon Kim, Jae Yeong Heo, Young Mee Park, Bo Mi Ku, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Keunchil Park, Siyoung Yang, Sang-Jun Ha, Yong Taik Lim & Myung-Ju Ahn. (2021) Therapeutic efficacy of cancer vaccine adjuvanted with nanoemulsion loaded with TLR7/8 agonist in lung cancer model. Nanomedicine: Nanotechnology, Biology and Medicine 37, pages 102415.
Crossref
Sanaz Sheikhzadeh, Nowruz Delirezh & Rahim Hobbenaghi. (2021) Mannosylated polylactic-co-glycolic acid (MN-PLGA) nanoparticles induce potent anti-tumor immunity in murine model of breast cancer. Biomedicine & Pharmacotherapy 142, pages 111962.
Crossref
Fan Yang, Kun Shi, Ying Hao, Yanpeng Jia, Qingya Liu, Yu Chen, Meng Pan, Liping Yuan, Yongyang Yu & Zhiyong Qian. (2021) Cyclophosphamide loaded thermo-responsive hydrogel system synergize with a hydrogel cancer vaccine to amplify cancer immunotherapy in a prime-boost manner. Bioactive Materials 6:10, pages 3036-3048.
Crossref
Kyong‐Su Park, Kristina Svennerholm, Rossella Crescitelli, Cecilia Lässer, Inta Gribonika & Jan Lötvall. (2021) Synthetic bacterial vesicles combined with tumour extracellular vesicles as cancer immunotherapy. Journal of Extracellular Vesicles 10:9.
Crossref
Lu Han, Ke Peng, Li-Ying Qiu, Meng Li, Jing-Hua Ruan, Li-Li He & Zhi-Xiang Yuan. (2021) Hitchhiking on Controlled-Release Drug Delivery Systems: Opportunities and Challenges for Cancer Vaccines. Frontiers in Pharmacology 12.
Crossref
Yingying Hou, Rong Liu, Xiaoyu Hong, Yunting Zhang, Shuting Bai, Xianjin Luo, Yuandong Zhang, Tao Gong, Zhirong Zhang & Xun Sun. (2021) Engineering a sustained release vaccine with a pathogen-mimicking manner for robust and durable immune responses. Journal of Controlled Release 333, pages 162-175.
Crossref
Marisa E. Aikins, Cheng Xu & James J. Moon. (2020) Engineered Nanoparticles for Cancer Vaccination and Immunotherapy. Accounts of Chemical Research 53:10, pages 2094-2105.
Crossref
Brett P. Gross, Khanidtha Chitphet, Amaraporn Wongrakpanich, Emad I. Wafa, Lyse A. Norian & Aliasger K. Salem. (2020) Biotinylated Streptavidin Surface Coating Improves the Efficacy of a PLGA Microparticle-Based Cancer Vaccine. Bioconjugate Chemistry 31:9, pages 2147-2157.
Crossref
Jingjing Liu, Lei Miao, Jiying Sui, Yanyun Hao & Guihua Huang. (2020) Nanoparticle cancer vaccines: Design considerations and recent advances. Asian Journal of Pharmaceutical Sciences 15:5, pages 576-590.
Crossref
Benjamin George Keselowsky, Abhinav Acharya & Jamal S. Lewis. 2020. Biomaterials Science. Biomaterials Science 747 775 .
Shengxian Li, Xiangru Feng, Jixue Wang, Weiguo Xu, Mohammad Ariful Islam, Tianmeng Sun, Zhigang Xie, Chunxi Wang, Jianxun Ding & Xuesi Chen. (2019) Multiantigenic Nanoformulations Activate Anticancer Immunity Depending on Size. Advanced Functional Materials 29:49, pages 1903391.
Crossref
Ashwin C. Parenky, Archana Akalkotkar, Nihal S. Mulla & Martin J. D'Souza. (2019) Harnessing T-cell activity against prostate cancer: A therapeutic microparticulate oral cancer vaccine. Vaccine 37:41, pages 6085-6092.
Crossref
Lipika Chablani, Suprita A. Tawde, Archana Akalkotkar & Martin J. D’Souza. (2019) Evaluation of a Particulate Breast Cancer Vaccine Delivered via Skin. The AAPS Journal 21:2.
Crossref
Rui Zhang, Margaret M. Billingsley & Michael J. Mitchell. (2018) Biomaterials for vaccine-based cancer immunotherapy. Journal of Controlled Release 292, pages 256-276.
Crossref
Shengxian Li, Xiangru Feng, Jixue Wang, Liang He, Chunxi Wang, Jianxun Ding & Xuesi Chen. (2018) Polymer nanoparticles as adjuvants in cancer immunotherapy. Nano Research 11:11, pages 5769-5786.
Crossref
Charles B Chesson & Andrew Zloza. (2017) Nanoparticles: augmenting tumor antigen presentation for vaccine and immunotherapy treatments of cancer. Nanomedicine 12:23, pages 2693-2706.
Crossref
Pallab Pradhan, Jardin Leleux, Jiaying Liu & Krishnendu Roy. (2017) A simple, clinically relevant therapeutic vaccine shows long-term protection in an aggressive, delayed-treatment B lymphoma model. JCI Insight 2:22.
Crossref
Wan-Lun Yan, Kuan-Yin Shen, Chun-Yuan Tien, Yu-An Chen & Shih-Jen Liu. (2017) Recent progress in GM-CSF-based cancer immunotherapy. Immunotherapy 9:4, pages 347-360.
Crossref
A.S. Morris, A. Wongrakpanich, S.M. Geary & A.K. Salem. 2017. Micro and Nanotechnology in Vaccine Development. Micro and Nanotechnology in Vaccine Development 171 183 .
Fadel S. Alyaqoub, Yasser A. Aldhamen, Benjamin J. Koestler, Eric L. Bruger, Sergey S. Seregin, Cristiane Pereira-Hicks, Sarah Godbehere, Christopher M. Waters & Andrea Amalfitano. (2016) In Vivo Synthesis of Cyclic-di-GMP Using a Recombinant Adenovirus Preferentially Improves Adaptive Immune Responses against Extracellular Antigens. The Journal of Immunology 196:4, pages 1741-1752.
Crossref
Eran Ophir, Sara Bobisse, George Coukos, Alexandre Harari & Lana E. Kandalaft. (2016) Personalized approaches to active immunotherapy in cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1865:1, pages 72-82.
Crossref
Sean M. Geary, Qiaohong Hu, Vijaya B. Joshi, Ned B. Bowden & Aliasger K. Salem. (2015) Diaminosulfide based polymer microparticles as cancer vaccine delivery systems. Journal of Controlled Release 220, pages 682-690.
Crossref
Cornelis J.M. Melief, Thorbald van Hall, Ramon Arens, Ferry Ossendorp & Sjoerd H. van der Burg. (2015) Therapeutic cancer vaccines. Journal of Clinical Investigation 125:9, pages 3401-3412.
Crossref
Feng-ying Huang, Feng-ru Huang, Bin Chen, Quan Liu, Hua Wang, Song-lin Zhou, Huan-ge Zhao, Yong-hao Huang, Ying-ying Lin & Guang-hong Tan. (2015) Microencapsulation of tumor lysates and live cell engineering with MIP-3α as an effective vaccine. Biomaterials 53, pages 554-565.
Crossref
Brett P. Gross, Amaraporn Wongrakpanich, Meghan B. Francis, Aliasger K. Salem & Lyse A. Norian. (2014) A Therapeutic Microparticle-Based Tumor Lysate Vaccine Reduces Spontaneous Metastases in Murine Breast Cancer. The AAPS Journal 16:6, pages 1194-1203.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.